150
Participants
Start Date
October 31, 2024
Primary Completion Date
December 31, 2028
Study Completion Date
May 31, 2029
Sotagliflozin
Oral sotagliflozin (200 mg per day)
Placebo
Inactive tablets identical to sotagliflozin tablets
RECRUITING
Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
RECRUITING
SUNY Upstate Medical University, Syracuse
RECRUITING
Cleveland Clinic Foundation, Cleveland
RECRUITING
Northwestern University Feinberg School of Medicine, Chicago
RECRUITING
Washington University, St Louis
RECRUITING
University of Texas Southwestern, Dallas
RECRUITING
Barbara Davis Center / University of Colorado Denver, Aurora
RECRUITING
Stanford University Medical Center, Stanford
RECRUITING
Oregon Health and Science University, Portland
RECRUITING
University of Washington, Seattle
RECRUITING
Providence Sacred Heart Medical Center, Spokane
RECRUITING
Joslin Diabetes Center, Boston
RECRUITING
Unversity of Calgary, Calgary
RECRUITING
Alberta Diabetes Institute, Edmonton
RECRUITING
St. Paul's Hospital, Vancouver
RECRUITING
LMC Diabetes and Endocrinology, Toronto
RECRUITING
Toronto General Hospital, Toronto
RECRUITING
Institut de Recherches Cliniques de Montréal, Montreal
Collaborators (2)
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
The Kidney Foundation of Canada
OTHER
The Cleveland Clinic
OTHER
University of Michigan
OTHER
University of Colorado, Denver
OTHER
Northwestern University
OTHER
Washington University School of Medicine
OTHER
State University of New York - Upstate Medical University
OTHER
Providence Medical Research Center
OTHER
Stanford University
OTHER
Montefiore Medical Center
OTHER
University of Toronto
OTHER
University Health Network, Toronto
OTHER
University of Calgary
OTHER
University of Alberta
OTHER
University of British Columbia
OTHER
Institut de Recherches Cliniques de Montreal
OTHER
LMC Diabetes & Endocrinology Ltd.
OTHER
Joslin Diabetes Center
OTHER
Lexicon Pharmaceuticals
INDUSTRY
DexCom, Inc.
INDUSTRY
University of Washington
OTHER
Breakthrough T1D
OTHER
Alessandro Doria
OTHER